News

The researchers found that the two treatments for empyema (a build-up of pus) in the space surrounding the lungs were about as effective as each other, but concluded

LP-261, which is predicted to bind to tubulin in a novel way, was developed by Locus using its proprietary computational drug design capabilities. This drug candidate is distinguished

The FDA generally follows the recommendations of its advisory committees, although it is not obligated to do so. Nabi Biopharmaceuticals submitted its biologic license application (BLA) for Nabi-HB

During a conference call the FDA expressed a concern relating to the potential for immunogenicity that might result from a possible interaction between calcitonin-salmon, the drug’s active ingredient,

The company further revealed that data from blood level exposure was sufficient to support once-a-day dosing. “We are very pleased with the outcome of the drug’s first human

Samaritan wanted to use the slogan “what happens in Vegas does not always stay in Vegas,” a play on the city’s popular “what happens here, stays here” tag

Cardeva, a long-acting form of b-type natriuretic peptide (BNP), is the most advanced compound in CoGenesys’ pipeline. Preclinical studies have demonstrated that Cardeva retains the pharmacological profile of

The Institute of Organic Chemistry and Biochemistry (IOCB) will use the donations to establish and support the Gilead Sciences Research Centre, which will consist of selected research groups

The product is the first ever once-daily single pill regimen to be approved for the treatment of HIV. It combines Sustiva, manufactured by Bristol-Myers Squibb, and Truvada, manufactured